Fulgent Genetics, Inc.
- FLGT
- NASDAQ
- Medical - Diagnostics & Research
- Genetic/Molecular Diagnostics
- COVID-19 Testing
$19.81
Today −7.17%Quote Oct 16, 2026, 08:00 PM UTC
−9.34%over the last month
Max drawdown −11.8%From 1-month high −11.8%3 months +1.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$545.1M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$19.00
−4.1% from here
Floor
$19.16
3.3% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about FLGTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Diagnostics & Research
Employees
1,315
Founded
2011